LAKISHA MONTGOMERY: Open Payments
NPI 1720643554 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 29 payments from 16 companies in 2025. Trend: 2023 $809 · 2024 $1,084 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $176 |
| Corcept Therapeutics | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Exeltis, USA Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 2 | $32 |
| Novo Nordisk Inc | 1 | $24 |
| Solventum Corporation | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $20 |
Products named: QULIPTA, Korlym, TRINTELLIX, SLYND, VRAYLAR, Veozah, Wegovy, ACTIV.A.C..
Industry payments across TX — which companies pay providers there.
